Antibody–Drug Conjugates Reshape Solid Tumor Therapy Amid Safety and Target Challenges
A new review in Holistic Integrative Oncology charts the rapid rise of antibody–drug conjugates in solid tumors while detailing the ...
A new review in Holistic Integrative Oncology charts the rapid rise of antibody–drug conjugates in solid tumors while detailing the ...
For patients with hepatocellular carcinoma, the first weeks of treatment are a diagnostic gray zone. The tumor is too large ...
A new review outlines how drug-tolerant persister cells hidden within minimal residual disease drive cancer relapse and how pathway inhibitors, ...
CRISPR-based synthetic lethal screening has identified the acetyltransferases p300 and CBP as essential chromatin partners for YAP-driven transcription in GNAQ-mutant ...
A new meta-analysis of 4,070 patients identifies EGFR L858R, poor performance status, and brain metastases as high-certency predictors of poorer ...
A randomized controlled trial published in Nature Communications reports that the oral CDK7 inhibitor samuraciclib combined with fulvestrant improved clinical ...
A 77-year-old woman's uterine tumor turned out to be metastatic lung adenocarcinoma, a case highlighting how immunohistochemistry and genomic sequencing ...
A UK study shows rapid whole genome sequencing cuts pediatric cancer diagnosis time from six weeks to three days while ...
New research shows that blocking the CXCL12/CXCR4 signaling axis in ovarian cancer cells produces a paradoxical biphasic response, with moderate ...
A fulminant, disseminated, EBV-negative extranodal NK/T-cell lymphoma in a previously healthy infant was diagnosed only after death, underscoring the rarity ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine